pancreatic hormone

Glucagon companies

Answer

Public registers name 10 licence holders, 11 ingredient makers with a drug master file, 3 bulk ingredient labelers, 14 US labelers, 196 trial sponsors and 4 recalling firms for Glucagon.

Each row is what a register states. A company named here is not endorsed or accused by this site.

MARKETING AUTHORISATION HOLDER

10 companies

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

Amphastar France Pharmaceuticals	Baqsimi (EMEA/H/C/003848), Authorised Regulator EMA
AMPHASTAR PHARMACEUTICALS, INC.	BAQSIMI (DIN 02492415), Marketed Regulator Health Canada
ELI LILLY AND COMPANY LIMITED	GLUCAGON AMPOULE 666 1MG (DIN 00015377), Cancelled Post Market Regulator Health Canada
ELI LILLY CANADA INC	GLUCAGON (DIN 02243297), Cancelled Post Market Regulator Health Canada
INTERNATIONAL MEDICATION SYSTEMS (UK) LIMITED	BAQSIMI 3 MG NASAL POWDER IN SINGLE-DOSE CONTAINER, PLGB 03265/0079, Authorised Regulator MHRA
LUPIN PHARMA CANADA LIMITED	LUPIN-GLUCAGON (DIN 02568969), Approved Regulator Health Canada
NOVO NORDISK AS	GLUCAGEN HYPOKIT 1 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, PL 04668/0027, Authorised Regulator MHRA
NOVO NORDISK CANADA INC	GLUCAGEN (DIN 02333619), Cancelled Post Market Regulator Health Canada GLUCAGEN HYPOKIT (DIN 02333627), Cancelled Post Market Regulator Health Canada
Strongbridge Dublin Limited	Ogluo (EMEA/H/C/005391), Authorised Regulator EMA
Zealand Pharma A/S	Zegalogue (EMEA/H/C/006214), Authorised Regulator EMA

API MANUFACTURER

11 companies

Filed a drug master file with FDA for the active ingredient.

AMBIOPHARM INC	DMF 26326, type II, active, submitted 2012-08-21 Regulator FDA drug master file list
BACHEM AG	DMF 18277, type II, active, submitted 2005-04-12 Regulator FDA drug master file list DMF 32703, type II, active, submitted 2018-06-08 Regulator FDA drug master file list
BACHEM CALIFORNIA	DMF 12297, type II, inactive, submitted 1996-12-27 Regulator FDA drug master file list
BACHEM FINE CHEMICALS INC	DMF 8253, type II, inactive, submitted 1989-10-19 Regulator FDA drug master file list
BACHEM INC	DMF 11110, type II, inactive, submitted 1994-09-30 Regulator FDA drug master file list
DIOSYNTH BV	DMF 5546, type II, inactive, submitted 1984-09-20 Regulator FDA drug master file list
FRESENIUS KABI IPSUM SRL	DMF 36017, type II, active, submitted 2022-12-22 Regulator FDA drug master file list
IAF BIOCHEM INTERNATIONAL INC	DMF 7773, type II, inactive, submitted 1988-10-31 Regulator FDA drug master file list
NOVO NORDISK AS	DMF 2961, type II, inactive, submitted 1977-06-07 Regulator FDA drug master file list DMF 3738, type II, inactive, submitted 1980-03-14 Regulator FDA drug master file list
PENINSULA LABS INC	DMF 10613, type II, inactive, submitted 1993-12-10 Regulator FDA drug master file list
RESTORAGEN INC	DMF 13906, type II, inactive, submitted 1998-12-22 Regulator FDA drug master file list

BULK INGREDIENT LABELER

3 companies

Lists the bulk active ingredient with FDA (NDC directory).

AMBIOPHARM INC	Glucagon, BULK INGREDIENT Regulator openFDA
BACHEM AG	Glucagon, BULK INGREDIENT Regulator openFDA
FRESENIUS KABI IPSUM SRL	GLUCAGON, BULK INGREDIENT Regulator openFDA

US LABELER

14 companies

Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.

A-S Medication Solutions	Glucagon, ANDA Regulator openFDA
American Regent, Inc.	Gvoke VialDx, NDA Regulator openFDA
AMPHASTAR PHARMACEUTICALS, INC.	Baqsimi, NDA Regulator openFDA Glucagon, ANDA Regulator openFDA
Catalent Pharma Solutions LLC	glucagon, DRUG FOR FURTHER PROCESSING Regulator openFDA
Cipla USA, Inc.	Glucagon, ANDA Regulator openFDA
Fresenius Kabi USA, LLC	Glucagon, NDA Regulator openFDA
Healthsource of New England LLC	Metabolism Manager, UNAPPROVED HOMEOPATHIC Regulator openFDA
HF Acquisition Co LLC, DBA HealthFirst	GLUCAGON, NDA Regulator openFDA
Lifetime Fat Loss Centers	Weight Management Support, UNAPPROVED HOMEOPATHIC Regulator openFDA
Lupin Pharmaceuticals Inc.	GLUCAGON, ANDA Regulator openFDA
Mylan Pharmaceuticals Inc.	Glucagon, ANDA Regulator openFDA
Professional Complementary Health Formulas	Glucagon 1555, UNAPPROVED HOMEOPATHIC Regulator openFDA
Sportpharm LLC	Baqsimi, NDA Regulator openFDA Glucagon, ANDA Regulator openFDA
Xeris Pharmaceuticals, Inc.	Gvoke HypoPen 0.5 mg Auto-Injector, NDA Regulator openFDA Gvoke HypoPen 1 mg Auto-Injector, NDA Regulator openFDA Gvoke Kit, NDA Regulator openFDA and 1 more entries

TRIAL SPONSOR

196 companies

Sponsors registered clinical trials of the peptide.

University Hospital, Gentofte, Copenhagen	26 registered trials Trial register ClinicalTrials.gov
Eli Lilly & Company	17 registered trials Trial register ClinicalTrials.gov
Xeris Pharmaceuticals	13 registered trials Trial register ClinicalTrials.gov
University Hospital, Basel, Switzerland	12 registered trials Trial register ClinicalTrials.gov
Zealand Pharma	12 registered trials Trial register ClinicalTrials.gov
Steno Diabetes Center Copenhagen	3 registered trials Trial register EU CTIS 7 registered trials Trial register ClinicalTrials.gov
Hvidovre University Hospital	9 registered trials Trial register ClinicalTrials.gov
Massachusetts General Hospital	8 registered trials Trial register ClinicalTrials.gov
University Health Network, Toronto	8 registered trials Trial register ClinicalTrials.gov
Institut de Recherches Cliniques de Montreal	7 registered trials Trial register ClinicalTrials.gov
Mayo Clinic	6 registered trials Trial register ClinicalTrials.gov
Novo Nordisk A/S	6 registered trials Trial register ClinicalTrials.gov
University of Aarhus	6 registered trials Trial register ClinicalTrials.gov
Nicolai Jacob Wewer Albrechtsen	5 registered trials Trial register ClinicalTrials.gov
Sanofi	5 registered trials Trial register ClinicalTrials.gov
The University of Texas Health Science Center at San Antonio	5 registered trials Trial register ClinicalTrials.gov
University of Copenhagen	5 registered trials Trial register ClinicalTrials.gov
Adrian Vella	4 registered trials Trial register ClinicalTrials.gov
Columbia University	4 registered trials Trial register ClinicalTrials.gov
Imperial College London	4 registered trials Trial register ClinicalTrials.gov
Johns Hopkins University	4 registered trials Trial register ClinicalTrials.gov
Joslin Diabetes Center	4 registered trials Trial register ClinicalTrials.gov
Lund University	4 registered trials Trial register ClinicalTrials.gov
University of Virginia	4 registered trials Trial register ClinicalTrials.gov
AdventHealth Translational Research Institute	3 registered trials Trial register ClinicalTrials.gov
Boehringer Ingelheim	3 registered trials Trial register ClinicalTrials.gov
Chinese PLA General Hospital	3 registered trials Trial register ClinicalTrials.gov
Legacy Health System	3 registered trials Trial register ClinicalTrials.gov
Ain Shams University	2 registered trials Trial register ClinicalTrials.gov
AstraZeneca	2 registered trials Trial register ClinicalTrials.gov
AstraZeneca AB	2 registered trials Trial register EU CTIS
Bispebjerg Hospital	2 registered trials Trial register ClinicalTrials.gov
Cambridge University Hospitals NHS Foundation Trust	2 registered trials Trial register ClinicalTrials.gov
Chen Wei Ren, MD	2 registered trials Trial register ClinicalTrials.gov
Children's Hospital Medical Center, Cincinnati	2 registered trials Trial register ClinicalTrials.gov
Copenhagen University Hospital, Rigshospitalet	2 registered trials Trial register ClinicalTrials.gov
Duke University	2 registered trials Trial register ClinicalTrials.gov
GlaxoSmithKline	2 registered trials Trial register ClinicalTrials.gov
Glostrup University Hospital, Copenhagen	2 registered trials Trial register ClinicalTrials.gov
Goldman, Butterwick, Fitzpatrick and Groff	2 registered trials Trial register ClinicalTrials.gov

Showing 40 of 196.

RECALLING FIRM

4 companies

Recalled a product naming the peptide (FDA enforcement report).

Eli Lilly & Company	Class I recall, Terminated, 2021-10-20 Regulator openFDA
Lupin Pharmaceuticals Inc.	Class II recall, Ongoing, 2026-07-08 Regulator openFDA
Mckesson Medical-Surgical Inc. Corporate Office	Class II recall, Terminated, 2022-06-15 Regulator openFDA
Novo Nordisk Inc	Class I recall, Terminated, 2016-12-28 Regulator openFDA

Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings. Trade between countries in all polypeptide hormones, Glucagon among them: trade.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.